Triple-negative breast cancer in African-American women: disparities versus biology.
about
Telomere Length and the Cancer-Atherosclerosis Trade-OffGSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and PathogenicityIdentification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast CancerA comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese womenThe diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies.Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization.Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/EthnicityApplication of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancerBarriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research.Shorter telomere length in Europeans than in Africans due to polygenetic adaptation.Trends of triple negative breast cancer research (2007-2015): A bibliometric study.Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancerDifferentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC).Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.Centrosome amplification: a suspect in breast cancer and racial disparities.Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992-2012.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992-2012).Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancerLow dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1.Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune TherapyKaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women.Race disparities in the contribution of miRNA isoforms and tRNA-derived fragments to triple-negative breast cancer.Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology.
P2860
Q26744052-602B26C3-D5AA-4B22-B00A-AF52D5AE19EAQ28275543-15990382-62E4-4597-A25B-4E8032EE4EAFQ28552581-A84725F9-9814-4171-9B81-BCE931DC1BEBQ33618290-46D2D990-865D-469A-A5BE-030C1B5088CDQ33618617-D3B27161-F300-4282-815F-701547E80663Q33821120-9B5B0849-C26E-4CAD-99CE-53B7217E2D67Q33848444-0BD3DF03-E468-4E5F-B4B3-8B374A2F3394Q34491805-B1939913-C9EC-4E93-86ED-FA7F5B2459A8Q34495412-0ABA17E0-6F5A-4A6B-914A-8F43B3199104Q35999539-2E10F7BE-507B-431D-9676-F54D5A76C82CQ36090325-46337E73-2D94-4492-9310-75E315A958C5Q36272043-2276075F-BB08-44C5-90CB-7D38C6236CE4Q36281065-E66C24C8-D78D-4BB3-AC65-5AD9F1ABF268Q36543401-C64E0684-650D-4DE9-82B7-130FE9C4EF0DQ36546746-FF46A21E-C956-444B-A100-F4EE59C7E313Q37097965-5B2FB126-9C41-4885-8A39-80AB78D87543Q37367965-FE69DE54-A839-4CC3-A9F1-B2595002EB45Q37433105-390136F5-F735-4CDF-8E11-373C1F6C16C5Q37652330-9C011D5A-6387-4E0F-939F-0607C1CE5351Q37694781-F701A5BB-11BA-4D60-8F11-32484528C7E6Q38694695-CAD42539-C135-405F-B51F-D382FDC0AC8EQ38750928-F0094EA2-56F5-4D9B-932F-15D7C4AE4295Q38758522-E737DF67-E899-4A20-BD1F-B5E9996E3619Q38780267-662EE74D-3CEE-493C-861D-80DB828927F0Q38934402-B518D7A8-D0BC-4C14-ACE7-680E0DE285E3Q39091739-1B9662C5-C110-43A5-A758-8A10900D557FQ39096966-4BA1372E-AFDC-41A6-B744-ECBEEDBF97EEQ39254902-FDB20AB8-E792-491C-BEB6-EBA6F861EBA2Q39373193-7D95CA26-879C-4ED9-AD32-C98359FAD5A0Q39510045-17C06C7A-F8EF-4038-81A4-EA228A61F103Q39972544-28B6A0D2-0442-451B-8C70-42901D115FFBQ40228854-197B52F8-A659-46FD-B085-3CA269790196Q40638709-275C3BF6-096B-4B06-9D61-3D9CACADE3DAQ40975730-5E72964B-6282-4594-964C-3CBB74D7532AQ41228730-769EF706-0126-428D-85A6-CB66B379B815Q42373147-33DED107-56D4-4D2C-BFA0-0C7FECA2782AQ42672834-E165A576-2034-4A92-95B6-8A4239B71FE8Q45732305-067C9EAC-230B-4C3F-9700-4EB4D4E8F35AQ46466893-C1494E1C-F28E-4C44-AD2F-CE3E9F70852BQ46759303-AC9C81A1-2F24-40A1-8DE2-3469C7CB0117
P2860
Triple-negative breast cancer in African-American women: disparities versus biology.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Triple-negative breast cancer in African-American women: disparities versus biology.
@ast
Triple-negative breast cancer in African-American women: disparities versus biology.
@en
type
label
Triple-negative breast cancer in African-American women: disparities versus biology.
@ast
Triple-negative breast cancer in African-American women: disparities versus biology.
@en
prefLabel
Triple-negative breast cancer in African-American women: disparities versus biology.
@ast
Triple-negative breast cancer in African-American women: disparities versus biology.
@en
P2093
P2860
P356
P1476
Triple-negative breast cancer in African-American women: disparities versus biology.
@en
P2093
Christopher Sistrunk
Eric C Dietze
Gustavo Miranda-Carboni
Ruth O'Regan
Victoria L Seewaldt
P2860
P2888
P304
P356
10.1038/NRC3896
P407
P577
2015-02-12T00:00:00Z
P5875
P6179
1047783208